{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:49:00Z","timestamp":1790023740028,"version":"4.0.1"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/crd.0000000000000007","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T10:13:34Z","timestamp":1407233614000},"page":"199-209","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacological and Nonpharmacological Treatment After Cardiac Surgery"],"prefix":"10.1097","volume":"22","author":[{"given":"Alessandro","family":"Durante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Rosario","family":"Limite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Peretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Laricchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mangieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Cianflone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20210203","first-page":"735","article-title":"2011 ACCFAHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines.","volume":"24","author":"Hillis","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R4-2-20210203","first-page":"431","article-title":"Human neutrophil mobilization during open heart surgery.","volume":"41","author":"Lojek","year":"1992","journal-title":"Physiol Res"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.","volume":"160","author":"Ma","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00000542-197806000-00005","article-title":"Blood pressure support during general anesthesia in a renin-dependent state in the rat.","volume":"48","author":"Miller","year":"1978","journal-title":"Anesthesiology"},{"key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/pgmj.2010.112987","article-title":"Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice.","volume":"87","author":"Auron","year":"2011","journal-title":"Postgrad Med J"},{"key":"R8-2-20210203","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ahj.2011.07.004","article-title":"Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery The impact of angiotensin-converting enzyme inhibitors, statins, and -blockers after coronary artery bypass graft surgery.","volume":"162","author":"Kalavrouziotis","year":"2011","journal-title":"Am Heart J"},{"key":"R9-2-20210203","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejcts.2003.12.019","article-title":"Impairment of cardiovascular autonomic control in patients early after cardiac surgery.","volume":"25","author":"Bauernschmitt","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1989.69.1.1","article-title":"A molecular basis for bidirectional communication between the immune and neuroendocrine systems.","volume":"69","author":"Blalock","year":"1989","journal-title":"Physiol Rev"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jc.2005-0265","article-title":"Septic shock and sepsis: a comparison of total and free plasma cortisol levels.","volume":"91","author":"Ho","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00075198-200208000-00002","article-title":"Steroids.","volume":"8","author":"Riad","year":"2002","journal-title":"Curr Opin Crit Care"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rcs.230","article-title":"Off-pump, minimally invasive and robotic coronary revascularization yield improved outcomes over traditional on-pump CABG.","volume":"5","author":"Atluri","year":"2009","journal-title":"Int J Med Robot"},{"key":"R15-2-20210203","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1213\/00000539-200210000-00004","article-title":"Remifentanil, fentanyl, and cardiac surgery: a double-blinded, randomized, controlled trial of costs and outcomes.","volume":"95","author":"Myles","year":"2002","journal-title":"Anesth Analg"},{"key":"R16-2-20210203","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1399-6576.2004.00474.x","article-title":"Supplemental remifentanil during coronary artery bypass grafting is followed by a transient postoperative cardiac depression.","volume":"48","author":"Pleym","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0003-4975(93)90894-N","article-title":"Hazards of postoperative atrial arrhythmias.","volume":"56","author":"Creswell","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"R18-2-20210203","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-5223(19)34483-6","article-title":"Atrial fibrillation after coronary artery bypass grafting.","volume":"97","author":"Fuller","year":"1989","journal-title":"Is it a disorder of the elderly J Thorac Cardiovasc Surg"},{"key":"R19-2-20210203","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5223(19)35525-4","article-title":"The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting.","volume":"100","author":"Leitch","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-2-20210203","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/0002-9149(90)90550-K","article-title":"Risk factors for atrial fibrillation after coronary artery bypass grafting.","volume":"66","author":"Crosby","year":"1990","journal-title":"Am J Cardiol"},{"key":"R21-2-20210203","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/01.CIR.94.3.390","article-title":"Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources.","volume":"94","author":"Aranki","year":"1996","journal-title":"Circulation"},{"key":"R22-2-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archinte.1972.00320030053005","article-title":"Hemodynamic effects of cardioversion in chronic atrial fibrillation. Special reference to coronary artery disease.","volume":"129","author":"Khaja","year":"1972","journal-title":"Arch Intern Med"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/021849230401200414","article-title":"Preoperative angiotensin-converting enzyme inhibition can cause severe post CPB vasodilationcurrent UK opinion.","volume":"12","author":"Devbhandari","year":"2004","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R25-2-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1213\/00000539-199503000-00007","article-title":"Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass.","volume":"80","author":"Tuman","year":"1995","journal-title":"Anesth Analg"},{"key":"R26-2-20210203","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.","volume":"116","author":"Argenziano","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.106.685073","article-title":"IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.","volume":"117","author":"Rouleau","year":"2008","journal-title":"Circulation"},{"key":"R28-2-20210203","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2009.07.008","article-title":"Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.","volume":"54","author":"Miceli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R29-2-20210203","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjcard.2010.04.028","article-title":"Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis.","volume":"106","author":"Dahl","year":"2010","journal-title":"Am J Cardiol"},{"key":"R30-2-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2007.11.016","article-title":"Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.","volume":"136","author":"Tsukashita","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R31-2-20210203","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9149(00)01428-4","article-title":"Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.","volume":"87","author":"Oosterga","year":"2001","journal-title":"Am J Cardiol"},{"key":"R32-2-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ahj.2004.04.004","article-title":"Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).","volume":"148","author":"Kjoller-Hansen","year":"2004","journal-title":"Am Heart J"},{"key":"R33-2-20210203","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2459\/JCM.0b013e32830a6daf","article-title":"Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.","volume":"9","author":"Benedetto","year":"2008","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R34-2-20210203","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.jss.2009.11.702","article-title":"Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery.","volume":"167","author":"Barodka","year":"2011","journal-title":"J Surg Res"},{"key":"R35-2-20210203","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.05271107","article-title":"Preoperative use of angiotensin-converting enzyme inhibitorsangiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery.","volume":"3","author":"Arora","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R36-2-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.111.059527","article-title":"Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality.","volume":"126","author":"Drenger","year":"2012","journal-title":"Circulation"},{"key":"R37-2-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.112.117671","article-title":"About fACE: perioperative use of angiotensin-converting enzyme inhibitors.","volume":"126","author":"Barodka","year":"2012","journal-title":"Circulation"},{"key":"R38-2-20210203","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/SLA.0b013e3181492c0d","article-title":"Statins for surgical patients.","volume":"247","author":"Williams","year":"2008","journal-title":"Ann Surg"},{"key":"R40-2-20210203","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"R41-2-20210203","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-dependent effects of statins.","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R44-2-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.RES.0000028004.76218.B8","article-title":"Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.","volume":"91","author":"Vecchione","year":"2002","journal-title":"Circ Res"},{"key":"R46-2-20210203","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jtcvs.2008.06.038","article-title":"Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.","volume":"136","author":"Mannacio","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R48-2-20210203","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jtcvs.2007.07.029","article-title":"Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.","volume":"134","author":"Thielmann","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R50-2-20210203","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jtcvs.2006.04.009","article-title":"Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.","volume":"132","author":"Collard","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R51-2-20210203","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jtcvs.2005.11.006","article-title":"Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study.","volume":"131","author":"Clark","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R53-2-20210203","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/eurheartj\/ehn198","article-title":"Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.","volume":"29","author":"Liakopoulos","year":"2008","journal-title":"Eur Heart J"},{"key":"R56-2-20210203","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.athoracsur.2010.10.061","article-title":"Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery.","volume":"91","author":"Mithani","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R57-2-20210203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1345\/aph.1P384","article-title":"Preoperative statins and acute kidney injury after cardiac surgery: utilization of a consensus definition of acute kidney injury.","volume":"45","author":"Bolesta","year":"2011","journal-title":"Ann Pharmacother"},{"key":"R58-2-20210203","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1213\/ANE.0b013e3181d8a078","article-title":"Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery.","volume":"111","author":"Argalious","year":"2010","journal-title":"Anesth Analg"},{"key":"R60-2-20210203","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(79)92010-5","article-title":"Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.","volume":"1","author":"Swedberg","year":"1979","journal-title":"Lancet"},{"key":"R61-2-20210203","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure.","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"R62-2-20210203","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJM199704033361426","article-title":"Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.","volume":"336","author":"Mangano","year":"1997","journal-title":"N Engl J Med"},{"key":"R63-2-20210203","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMe058076","article-title":"Beta-blocker therapy in noncardiac surgery.","volume":"353","author":"Poldermans","year":"2005","journal-title":"N Engl J Med"},{"key":"R64-2-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2003.147","article-title":"Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the -Blocker Length of Stay (BLOS) study.","volume":"145","author":"Connolly","year":"2003","journal-title":"Am Heart J"},{"key":"R65-2-20210203","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","article-title":"Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis.","volume":"27","author":"Burgess","year":"2006","journal-title":"Eur Heart J"},{"key":"R66-2-20210203","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00000539-200212000-00005","article-title":"The association between heart rate and in-hospital mortality after coronary artery bypass graft surgery.","volume":"95","author":"Fillinger","year":"2002","journal-title":"Anesth Analg"},{"key":"R68-2-20210203","first-page":"286","article-title":"Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival.","volume":"88","author":"Weightman","year":"1999","journal-title":"Anesth Analg"},{"key":"R70-2-20210203","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0003-4975(98)00157-X","article-title":"Intravenous diltiazem and acute renal failure after cardiac operations.","volume":"65","author":"Young","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"R71-2-20210203","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1053\/euhj.2001.2953","article-title":"Vasodilator pre-treatment of human radial arteries.","volume":"22","author":"Coonar","year":"2001","journal-title":"Eur Heart J"},{"key":"R73-2-20210203","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.athoracsur.2007.10.042","article-title":"Clinical and potential use of pharmacological agents to reduce radial artery spasm in coronary artery surgery.","volume":"85","author":"Attaran","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R74-2-20210203","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1213\/01.ANE.0000121769.62638.EB","article-title":"Maintenance of normoglycemia during cardiac surgery.","volume":"99","author":"Carvalho","year":"2004","journal-title":"Anesth Analg"},{"key":"R75-2-20210203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/tcic.9.3.118.128","article-title":"The hyperglycemic response to surgery: pathophysiology, clinical implications and modification by the anesthetic technique.","volume":"9","author":"Schricker","year":"1998","journal-title":"Clin Intensive Care"},{"key":"R76-2-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.athoracsur.2008.11.011","article-title":"Society of Thoracic Surgeons Blood Glucose Guideline Task Force. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery.","volume":"87","author":"Lazar","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R77-2-20210203","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.CIR.0000121747.71054.79","article-title":"Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.","volume":"109","author":"Lazar","year":"2004","journal-title":"Circulation"},{"key":"R78-2-20210203","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","article-title":"Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.","volume":"125","author":"Furnary","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R79-2-20210203","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients.","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"R80-2-20210203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00000542-200510000-00006","article-title":"Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients.","volume":"103","author":"Ouattara","year":"2005","journal-title":"Anesthesiology"},{"key":"R81-2-20210203","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jtcvs.2005.05.049","article-title":"Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery.","volume":"130","author":"Doenst","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R82-2-20210203","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.49.531","article-title":"Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting.","volume":"49","author":"Guvener","year":"2002","journal-title":"Endocr J"},{"key":"R83-2-20210203","doi-asserted-by":"crossref","first-page":"862","DOI":"10.4065\/80.7.862","article-title":"Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients.","volume":"80","author":"Gandhi","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"R84-2-20210203","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1540-8191.2012.01471.x","article-title":"A primer for achieving glycemic control in the cardiac surgical patient.","volume":"27","author":"McDonnell","year":"2012","journal-title":"J Card Surg"},{"key":"R85-2-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-146-4-200702200-00002","article-title":"Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.","volume":"146","author":"Gandhi","year":"2007","journal-title":"Ann Intern Med"},{"key":"R86-2-20210203","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients.","volume":"360","author":"Finfer","year":"2009","journal-title":"N Eng J Med"},{"key":"R87-2-20210203","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/eurheartj\/ehi855","article-title":"Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life.","volume":"27","author":"Ingels","year":"2006","journal-title":"Eur Heart J"},{"key":"R88-2-20210203","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","article-title":"Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.","volume":"31","author":"Komajda","year":"2010","journal-title":"Eur Heart J"},{"key":"R89-2-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/11587580-000000000-00000","article-title":"Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.","volume":"11","author":"Hernandez","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"R90-2-20210203","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.2337\/dc07-0717","article-title":"PROactive Investigators. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).","volume":"30","author":"Erdmann","year":"2007","journal-title":"Diabetes Care"},{"key":"R91-2-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ypmed.2007.05.014","article-title":"Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging.","volume":"45","author":"Talbot","year":"2007","journal-title":"Prev Med"},{"key":"R92-2-20210203","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/HJR.0b013e3280144470","article-title":"Intensity versus duration of walking, impact on mortality: the Copenhagen City Heart Study.","volume":"14","author":"Schnohr","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"R93-2-20210203","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjmed.2004.01.009","article-title":"Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.","volume":"116","author":"Taylor","year":"2004","journal-title":"Am J Med"},{"key":"R94-2-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmj.328.7441.711-b","article-title":"ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).","volume":"328","author":"Piepoli","year":"2004","journal-title":"BMJ"},{"key":"R96-2-20210203","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1249\/01.MSS.0000145443.02568.7A","article-title":"Physical activity and mortality across cardiovascular disease risk groups.","volume":"36","author":"Richardson","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"R97-2-20210203","first-page":"3","article-title":"Rehabilitation of patients with cardiovascular diseases. Report of a who expert committee.","volume":"270","author":"Brown","year":"1964","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R100-2-20210203","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Association for Cardiovascular Prevention Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"R101-2-20210203","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHAACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.","volume":"58","author":"Smith","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R102-2-20210203","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","article-title":"American College of Cardiology; American Heart Association; Canadian Cardiovascular Society. ACCAHA guidelines for the management of patients with ST-elevation myocardial infarctionexecutive summary. A report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R103-2-20210203","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","article-title":"American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACCAHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarctionsummary article: a report of the American College of CardiologyAmerican Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).","volume":"40","author":"Braunwald","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R104-2-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000047041.66447.29","article-title":"American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee on the Management of Patients With Chronic Stable Angina. ACCAHA 2002 guideline update for the management of patients with chronic stable anginasummary article: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).","volume":"107","author":"Gibbons","year":"2003","journal-title":"Circulation"},{"key":"R106-2-20210203","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.pmrj.2011.06.007","article-title":"Cardiac rehabilitation after heart valve surgery.","volume":"3","author":"Kiel","year":"2011","journal-title":"PM R"},{"key":"R107-2-20210203","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1378\/chest.123.6.2104","article-title":"Cardiac rehabilitation following percutaneous revascularization, heart transplant, heart valve surgery, and for chronic heart failure.","volume":"123","author":"Stewart","year":"2003","journal-title":"Chest"},{"key":"R108-2-20210203","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1161\/01.CIR.99.25.3255","article-title":"Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial.","volume":"99","author":"Goy","year":"1999","journal-title":"Circulation"},{"key":"R110-2-20210203","first-page":"25","article-title":"Effects of cardiac rehabilitation program on right ventricular function after coronary artery bypass graft surgery.","volume":"7","author":"Zoroufian","year":"2012","journal-title":"J Tehran Heart Cent"},{"key":"R112-2-20210203","first-page":"394","article-title":"Topical problems in rehabilitation following valve replacement.","volume":"26","author":"Gladkova","year":"1984","journal-title":"Cor Vasa"},{"key":"R113-2-20210203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/hrt.2008.160010","article-title":"Predicting outcome after valve replacement.","volume":"96","author":"Rimington","year":"2010","journal-title":"Heart"},{"key":"R114-2-20210203","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/hrt.44.6.638","article-title":"Physical training after heart valve replacement.","volume":"44","author":"Newell","year":"1980","journal-title":"Br Heart J"},{"key":"R115-2-20210203","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/0003-4819-143-9-200511010-00010","article-title":"Meta-analysis: secondary prevention programs for patients with coronary artery disease.","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"R116-2-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008483-199701000-00004","article-title":"Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation.","volume":"17","author":"Engblom","year":"1997","journal-title":"J Cardiopulm Rehabil"},{"key":"R117-2-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s11748-010-0665-0","article-title":"Outcome after valve surgery in octogenarians and efficacy of early mobilization with early cardiac rehabilitation.","volume":"58","author":"Nakamura","year":"2010","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R118-2-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1472-6963-12-243","article-title":"A systematic review of economic evaluations of cardiac rehabilitation.","volume":"12","author":"Wong","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"R119-2-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9149(96)00748-5","article-title":"Compliance and efficacy of cardiac rehabilitation and risk factor modification in the medically indigent.","volume":"79","author":"Friedman","year":"1997","journal-title":"Am J Cardiol"},{"key":"R120-2-20210203","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.rehab.2012.05.002","article-title":"Accelerometer as a tool to assess sedentarity and adherence to physical activity recommendations after cardiac rehabilitation program.","volume":"55","author":"Guiraud","year":"2012","journal-title":"Ann Phys Rehabil Med"},{"key":"R121-2-20210203","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.hjr.0000201513.13343.97","article-title":"Determinants of physical activity after hospitalization for coronary artery disease: the Tracking Exercise After Cardiac Hospitalization (TEACH) Study.","volume":"13","author":"Reid","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"R122-2-20210203","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.apmr.2012.06.027","article-title":"Telephone support oriented by accelerometric measurements enhances adherence to physical activity recommendations in noncompliant patients after a cardiac rehabilitation program.","volume":"93","author":"Guiraud","year":"2012","journal-title":"Arch Phys Med Rehabil"},{"key":"R123-2-20210203","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.7326\/0003-4819-135-12-200112180-00010","article-title":"Atrial fibrillation after cardiac surgery.","volume":"135","author":"Maisel","year":"2001","journal-title":"Ann Intern Med"},{"key":"R124-2-20210203","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/0735-1097(95)00047-8","article-title":"Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation.","volume":"25","author":"Pavri","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R125-2-20210203","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/01.CIR.101.12.1403","article-title":"Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification.","volume":"101","author":"Zaman","year":"2000","journal-title":"Circulation"},{"key":"R127-2-20210203","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mhj.2000.111104","article-title":"Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.","volume":"140","author":"Lee","year":"2000","journal-title":"Am Heart J"},{"key":"R131-2-20210203","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACCAHAESC 2006 guidelines for the management of patients with AF: a report of the American College of CardiologyAmerican Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T16:58:03Z","timestamp":1649869083000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201409000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000007","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}